Literature DB >> 12466426

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.

Jorge Flores-Hernández1, Carlos Cepeda, Elizabeth Hernández-Echeagaray, Christopher R Calvert, Eve S Jokel, Allen A Fienberg, Paul Greengard, Michael S Levine.   

Abstract

Dopamine (DA), via activation of D1 receptors, enhances N-methyl-D-aspartate (NMDA)-evoked responses in striatal neurons. The present investigation examined further the properties of this enhancement and the potential mechanisms by which this enhancement might be effected. Dissociated medium-sized striatal neurons were obtained from intact rats and mice or mutant mice lacking the DA and cyclic adenosine 3',5' monophosphate (cAMP)-regulated phosphoprotein of M(R) 32,000 (DARPP-32). NMDA (10-1,000 microM) induced inward currents in all neurons. In acutely dissociated neurons from intact rats or mice, activation of D1 receptors with the selective agonist, SKF 81297, produced a dose-dependent enhancement of NMDA currents. This enhancement was reduced by the selective D1 receptor antagonist SKF 83566. Quinpirole, a D2 receptor agonist alone, produced small reductions of NMDA currents. However, it consistently and significantly reduced the enhancement of NMDA currents by D1 agonists. In dissociated striatal neurons, in conditions that minimized the contributions of voltage-gated Ca(2+) conductances, the D1-induced potentiation was not altered by blockade of L-type voltage-gated Ca(2+) conductances in contrast to results in slices. The DARPP-32 signaling pathway has an important role in D1 modulation of NMDA currents. In mice lacking DARPP-32, the enhancement was significantly reduced. Furthermore, okadaic acid, a protein phosphatase 1 (PP-1) inhibitor, increased D1-induced potentiation, suggesting that constitutively active PP-1 attenuates D1-induced potentiation. Finally, activation of D1 receptors produced differential effects on NMDA and gamma aminobutyric acid (GABA)-induced currents in the same cells, enhancing NMDA currents and inhibiting GABA currents. Thus simultaneous activation of D1, NMDA, and GABA receptors could predispose medium-sized spiny neurons toward excitation. Taken together, the present findings indicate that the unique potentiation of NMDA receptor function by activation of the D1 receptor signaling cascade can be controlled by multiple mechanisms and has major influences on neuronal function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466426     DOI: 10.1152/jn.00361.2002

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  87 in total

1.  Differential effects of cocaine-induced seizures and lethality on M(1)-like muscarinic and dopaminergic D (1)- and D (2)-like binding receptors in mice brain.

Authors:  Danielle Silveira Macêdo; Silvânia Maria Mendes Vasconcelos; Manoel Andrade-Neto; Marta Maria França Fonteles; Lissiana Magna Vasconcelos Aguiar; Glauce Socorro Barros Viana; Francisca Cléa Florençode Sousa
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

2.  Dopamine-glutamate interplay in the ventral striatum modulates spatial learning in a receptor subtype-dependent manner.

Authors:  Roberto Coccurello; Alberto Oliverio; Andrea Mele
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

Review 3.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

4.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

5.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

6.  Dopamine receptor 2 regulates L-type voltage-gated calcium channel in primary cultured mouse midbrain neural network.

Authors:  Fumie Yasumoto; Takayuki Negishi; Yoshiyuki Ishii; Shigeru Kyuwa; Yoichiro Kuroda; Yasuhiro Yoshikawa
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

7.  Impairing effect of amphetamine and concomitant ionotropic glutamate receptors blockade in the ventral striatum on spatial learning in mice.

Authors:  Roberto Coccurello; Alberto Oliverio; Andrea Mele
Journal:  Psychopharmacology (Berl)       Date:  2013-02-05       Impact factor: 4.530

8.  The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression.

Authors:  Susanna Waters; Henrik Ponten; Malin Edling; Boel Svanberg; Daniel Klamer; Nicholas Waters
Journal:  J Neural Transm (Vienna)       Date:  2014-05-11       Impact factor: 3.575

9.  Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Authors:  Yan-Chun Li; Dong Xi; Joy Roman; Yue-Qiao Huang; Wen-Jun Gao
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

10.  Cholinergic direct inhibition of N-methyl-D aspartate receptor-mediated currents in the rat neocortex.

Authors:  Jorge Flores-Hernandez; Humberto Salgado; Victor De La Rosa; Tania Avila-Ruiz; Oswaldo Torres-Ramirez; Gustavo Lopez-Lopez; Marco Atzori
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.